M&As this week: inviCRO, Inotek Pharmaceuticals Corporation


inviCRO has completed the acquisition of UK-based translational research company Imanova.

Based in the US, the acquirer company is an imaging services and software provider, which expects the acquisition to help expand its imaging capabilities.

"Biopharmaceutical company Inotek Pharmaceuticals Corporation plans to merge with gene therapy company Rocket Pharmaceuticals."

Biopharmaceutical company Inotek Pharmaceuticals Corporation plans to merge with gene therapy company Rocket Pharmaceuticals.

The merged entity will focus on the development of gene therapies for treating rare diseases.

Both companies involved in the merger are based in the US.